Valorization of Pharmaceutical Waste by Recovery of Active Pharmaceutical Ingredients from Expired or Unused Finished Pharmaceutical Products with Thermodynamic Modeling
Jaber Yousefi Seyf*, Fatemeh Zarei and Amir Jalalinejad,
{"title":"Valorization of Pharmaceutical Waste by Recovery of Active Pharmaceutical Ingredients from Expired or Unused Finished Pharmaceutical Products with Thermodynamic Modeling","authors":"Jaber Yousefi Seyf*, Fatemeh Zarei and Amir Jalalinejad, ","doi":"10.1021/acs.oprd.5c0009310.1021/acs.oprd.5c00093","DOIUrl":null,"url":null,"abstract":"<p >This study aims to investigate the possibility of recovering active pharmaceutical ingredients (APIs) from expired or unused finished pharmaceutical products (FPPs). Five pharmaceuticals, including ibuprofen, acetaminophen, lamotrigine, phenobarbital, and carbamazepine, were chosen as FPP models. At the beginning of the study, thermodynamic modeling of pharmaceutical solubility was done by the NRTL-SAC and UNIFAC-DMD activity coefficient models in order to screen the 62 approved solvents as determined by the Food and Drug Administration. These models reduce the time and cost associated with the experimental tries. Solid–liquid extraction, filtration, and crystallization are the three main unit operations that are used to purify pharmaceuticals. Results showed that the efficiency of the active pharmaceutical ingredient recovery is between 47 and 81%, mainly above 50%. Also, the purity of the recovered APIs, as the most important factor, was analyzed using melting point FT-IR, UV, high-performance liquid chromatography, and <sup>1</sup>H NMR techniques. Results show that the purity obtained for most recovered APIs is near 100%. So, the purified APIs can be reused in formulation by finished product companies or as starting material in synthesizing derivatives in organic chemistry to obtain new molecules. The present research met the green chemistry criteria and shows significant importance from environmental and economic points of view.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 5","pages":"1333–1344 1333–1344"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.oprd.5c00093","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to investigate the possibility of recovering active pharmaceutical ingredients (APIs) from expired or unused finished pharmaceutical products (FPPs). Five pharmaceuticals, including ibuprofen, acetaminophen, lamotrigine, phenobarbital, and carbamazepine, were chosen as FPP models. At the beginning of the study, thermodynamic modeling of pharmaceutical solubility was done by the NRTL-SAC and UNIFAC-DMD activity coefficient models in order to screen the 62 approved solvents as determined by the Food and Drug Administration. These models reduce the time and cost associated with the experimental tries. Solid–liquid extraction, filtration, and crystallization are the three main unit operations that are used to purify pharmaceuticals. Results showed that the efficiency of the active pharmaceutical ingredient recovery is between 47 and 81%, mainly above 50%. Also, the purity of the recovered APIs, as the most important factor, was analyzed using melting point FT-IR, UV, high-performance liquid chromatography, and 1H NMR techniques. Results show that the purity obtained for most recovered APIs is near 100%. So, the purified APIs can be reused in formulation by finished product companies or as starting material in synthesizing derivatives in organic chemistry to obtain new molecules. The present research met the green chemistry criteria and shows significant importance from environmental and economic points of view.
期刊介绍:
The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.